Nuvalent, Inc. (NUVL)
Jul 15, 2026 - NUVL was delisted (reason: acquired by GSK)
123.96
+0.02 (0.02%)
Inactive · Last trade price on Jul 14, 2026

Nuvalent Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
9,8347,8125,5624,6091,681919
Market Cap Growth
71.88%40.45%20.68%174.21%82.83%-
Enterprise Value
8,5476,8684,3944,1961,441617
Last Close Price
-100.5978.2873.5929.7819.04

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
8.336.265.206.583.633.23
P/TBV Ratio
8.376.265.206.583.633.23

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Debt / Equity Ratio
-1.10-1.10-1.04-1.03-1.02-1.01
Quick Ratio
15.8915.0520.7022.6224.2432.79
Current Ratio
16.1415.2720.9622.8324.5433.08
Return on Equity (ROE)
-41.19%-36.70%-29.46%-21.70%-21.89%-32.06%
Return on Assets (ROA)
-22.51%-20.27%-18.70%-15.38%-13.87%-18.81%
Return on Capital Employed (ROCE)
-35.10%-31.40%-25.80%-21.30%-18.60%-16.10%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-4.58%-5.45%-4.69%-2.74%-4.87%-5.04%
Buyback Yield / Dilution
-9.05%-9.45%-14.06%-17.22%-128.01%-659.75%
SEC Filings: 10-K · 10-Q